Ardent Health Partners, LLC (NYSE:ARDT - Free Report) - Investment analysts at Leerink Partnrs reduced their Q1 2025 earnings estimates for Ardent Health Partners in a research report issued to clients and investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now expects that the company will earn $0.20 per share for the quarter, down from their prior estimate of $0.33. The consensus estimate for Ardent Health Partners' current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners' Q2 2025 earnings at $0.61 EPS.
Ardent Health Partners (NYSE:ARDT - Get Free Report) last announced its quarterly earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analyst estimates of $1.48 billion.
Other equities analysts have also issued reports about the company. Morgan Stanley decreased their price objective on Ardent Health Partners from $23.50 to $22.00 and set an "overweight" rating for the company in a report on Tuesday, January 21st. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $20.00 price target on shares of Ardent Health Partners in a research note on Tuesday, December 17th. Mizuho cut their price objective on shares of Ardent Health Partners from $19.00 to $18.00 and set an "outperform" rating on the stock in a research note on Wednesday. Stephens reiterated an "overweight" rating and issued a $22.00 target price on shares of Ardent Health Partners in a research report on Tuesday, April 1st. Finally, Royal Bank of Canada dropped their price target on shares of Ardent Health Partners from $23.00 to $21.00 and set an "outperform" rating on the stock in a research report on Tuesday, March 4th. Two analysts have rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Buy" and an average target price of $20.58.
Check Out Our Latest Research Report on ARDT
Ardent Health Partners Price Performance
Ardent Health Partners stock traded up $0.81 during midday trading on Friday, reaching $12.69. 139,198 shares of the stock traded hands, compared to its average volume of 406,277. The firm has a fifty day moving average price of $14.08 and a two-hundred day moving average price of $15.94. Ardent Health Partners has a fifty-two week low of $11.60 and a fifty-two week high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.
Hedge Funds Weigh In On Ardent Health Partners
A number of institutional investors have recently bought and sold shares of ARDT. Ventas Inc. purchased a new stake in Ardent Health Partners during the fourth quarter valued at about $159,570,000. Point72 Asset Management L.P. lifted its position in shares of Ardent Health Partners by 7.9% in the 4th quarter. Point72 Asset Management L.P. now owns 1,609,720 shares of the company's stock valued at $27,494,000 after acquiring an additional 117,421 shares in the last quarter. Wellington Management Group LLP acquired a new position in Ardent Health Partners in the 3rd quarter worth approximately $28,724,000. Franklin Resources Inc. grew its position in Ardent Health Partners by 9.4% during the 4th quarter. Franklin Resources Inc. now owns 917,926 shares of the company's stock worth $15,678,000 after purchasing an additional 78,575 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in Ardent Health Partners by 9.2% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 779,601 shares of the company's stock worth $13,136,000 after purchasing an additional 65,833 shares in the last quarter.
Ardent Health Partners Company Profile
(
Get Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
See Also
Before you consider Ardent Health Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health Partners wasn't on the list.
While Ardent Health Partners currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Like this article? Share it with a colleague.
Link copied to clipboard.
